STOCK TITAN

NUS Form 4: Director Disposes 32,437 Class A Shares, Holdings Remain Indirectly Held

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Daniel W. Campbell, a director of Nu Skin Enterprises (NUS), reported open-market sales of Class A common stock on 08/29/2025. The filing shows two disposal transactions: 9,046 shares sold at a weighted-average price of $12.12 and 23,391 shares sold at a weighted-average price of $12.10, for total reported disposals of 32,437 shares. After the transactions the report shows 39,216 shares held directly and 53,375 shares held indirectly, including shares held by an irrevocable family trust and by a limited liability company controlled by the reporting person and his spouse.

Positive

  • None.

Negative

  • Director sold 32,437 shares in open-market transactions, reducing direct holdings reported on the form
  • Material portion of holdings held indirectly (53,375 shares) via an irrevocable family trust and an LLC, which may be less liquid from the issuer's perspective

Insights

TL;DR: Director executed multi-lot open-market sales totaling 32,437 NUS shares at ~ $12.10–$12.12 per share.

The sales are reported as routine open-market dispositions across multiple trades at slightly varying prices with weighted-average prices disclosed. Holdings remain both direct and indirect, indicating retained investment exposure via an irrevocable family trust and an LLC. The disclosure is standard for Section 16 insiders and provides full price range transparency for the trades.

TL;DR: Insider disclosed planned or executed disposals with ownership now split between direct and indirect holdings.

The form documents compliance with Section 16 reporting for a director-level insider. Indirect ownership through a family trust and an LLC is explicitly disclosed, which clarifies beneficial ownership structure. No derivative transactions or other compensatory issuances are reported, limiting governance complexity in this filing.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CAMPBELL DANIEL W

(Last) (First) (Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET

(Street)
PROVO UT 84601

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/29/2025 S 9,046 D $12.12(1) 39,216 D
Class A Common Stock 08/29/2025 S 23,391 D $12.1(2) 53,375 I By an irrevocable family trust
Class A Common Stock 10,010 I By a limited liability company(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.10 to $12.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
3. Limited liability company owned and controlled by the Reporting Person and his spouse.
/s/ Gregory Belliston as Attorney-in-Fact for Daniel Campbell 08/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did the Form 4 for NUS disclose?

The Form 4 reports that director Daniel W. Campbell sold a total of 32,437 Class A shares in open-market transactions on 08/29/2025 at weighted-average prices of $12.12 and $12.10.

How many NUS shares does Daniel W. Campbell own after these transactions?

The filing shows 39,216 shares held directly and 53,375 shares held indirectly following the reported transactions.

What forms of indirect ownership are disclosed in the filing?

Indirect ownership is disclosed as shares held by an irrevocable family trust and by a limited liability company owned and controlled by the reporting person and his spouse.

Were any derivative securities reported in this Form 4 for NUS?

No derivative securities were reported; Table II is empty and the form only documents non-derivative common stock dispositions.

Does the filing disclose the exact per-trade prices for the sales?

The filing provides weighted-average prices and price ranges: sales ranged from $12.10 to $12.12, and the reporting person offers to provide full breakdowns on request.
Nu Skin Enter

NYSE:NUS

NUS Rankings

NUS Latest News

NUS Latest SEC Filings

NUS Stock Data

402.95M
46.44M
2.16%
74.97%
3.89%
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO